Which has the lower trailing P/E, UTHR or WAT?

UTHR has the lower trailing P/E: UTHR trades at 19.52 and WAT at 47.17. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, UTHR or WAT?

Over the past five years, UTHR grew revenue faster — UTHR at a 16.05% CAGR versus WAT at 8.48%.

Is UTHR or WAT more profitable?

UTHR runs the higher net margin — UTHR at 40.61% versus WAT at 11.91%.

How have UTHR and WAT total returns compared?

Over the past 10 years, UTHR delivered 16.65% and WAT delivered 8.96% annualized total return. Past performance doesn't predict future results.

United Therapeutics Corporation (UTHR) vs Waters Corporation (WAT)

A side-by-side comparison of United Therapeutics Corporation and Waters Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.

UTHR

United Therapeutics Corporation

$22.23B

$523.63HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT

WAT

Waters Corporation

$25.02B

$383.90HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT

Total return — UTHR vs WAT

growth of $100 · dividends reinvested · last 27y

UTHR +8563.6%WAT +1307.4%UTHR compounded faster

Log scale — wide-divergence pair

UTHR WAT

UTHR vs WAT: by the numbers

•WAT is the larger company ($25.02B vs $22.23B market cap).
•UTHR trades at the lower trailing earnings multiple (19.52 vs 47.17 P/E), one valuation lens rather than an overall verdict.
•UTHR converts more revenue to profit (40.61% vs 11.91% net margin).
•UTHR grew revenue faster over the past five years (16.05% vs 8.48% CAGR).

Metrics side by side

Valuation

Metric	UTHR	WAT
P/E ratio	19.52	47.17
Forward P/E	18.94	25.56
P/S ratio	7.86	8.09
P/B ratio	4.22	1.99
PEG ratio	1.16	75.61
EV / EBITDA	15.63	37.36
FCF yield	4.08%	0.87%

Profitability

Metric	UTHR	WAT
Gross margin	86.58%	55.02%
Operating margin	45.34%	28.22%
Net margin	40.61%	11.91%
ROE	21.82%	2.94%
ROIC	16.13%	17.57%

Growth (annualized)

Metric	UTHR	WAT
Revenue CAGR (5Y)	16.05%	8.48%
EPS CAGR (5Y)	20.93%	5.16%
FCF CAGR (5Y)	12.12%	-17.63%
Total return CAGR (5Y)	23.16%	-0.39%

Frequently asked

Which has the lower trailing P/E, UTHR or WAT?: UTHR has the lower trailing P/E: UTHR trades at 19.52 and WAT at 47.17. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, UTHR or WAT?: Over the past five years, UTHR grew revenue faster — UTHR at a 16.05% CAGR versus WAT at 8.48%.
Is UTHR or WAT more profitable?: UTHR runs the higher net margin — UTHR at 40.61% versus WAT at 11.91%.
How have UTHR and WAT total returns compared?: Over the past 10 years, UTHR delivered 16.65% and WAT delivered 8.96% annualized total return. Past performance doesn't predict future results.

Go deeper

Full UTHR analysis Full WAT analysis Interactive comparison tool

Dig into the metrics

United Therapeutics P/E ratio Waters P/E ratio United Therapeutics dividend yield Waters dividend yield United Therapeutics ROE Waters ROE United Therapeutics operating margin Waters operating margin United Therapeutics revenue growth Waters revenue growth United Therapeutics free cash flow Waters free cash flow

United Therapeutics & Waters appear in these rankings

Fastest Revenue Growth Stocks Highest Operating Margin Stocks Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.